Refractory Graft-versus-host disease

Also known as: Refractory Graft versus host disease

Drug	Drug Name	Drug Description
DB01041	Thalidomide	A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum.

Drug	Drug Name	Target	Type
DB01041	Thalidomide	Cytochrome P450 2C19	enzyme
DB01041	Thalidomide	Cytochrome P450 2C9	enzyme
DB01041	Thalidomide	Prostaglandin G/H synthase 1	enzyme
DB01041	Thalidomide	Prostaglandin G/H synthase 2	enzyme
DB01041	Thalidomide	Cytochrome P450 3A5	enzyme
DB01041	Thalidomide	DNA	target
DB01041	Thalidomide	Protein cereblon	target
DB01041	Thalidomide	alpha1-acid glycoprotein	target
DB01041	Thalidomide	Cytochrome P450 3A4	enzyme
DB01041	Thalidomide	Cytochrome P450 1A1	enzyme
DB01041	Thalidomide	Cytochrome P450 2B6	enzyme

Drug	Drug Name	Phase	Status	Count